FdaApplication
NDA 022206
Identifiers
- fda_app_no: NDA022206
Properties
| Property | Value |
|---|---|
| applicant_name | ABBVIE INC |
| application_type | NDA |
| approval_date | 2008-10-08 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RAPAFLO | SILODOSIN | 4MG | CAPSULE;ORAL |
| RAPAFLO | SILODOSIN | 8MG | CAPSULE;ORAL |
2 products